Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo.
暂无分享,去创建一个
T. Asahara | Douglas Losordo | O. Tepper | T. Murayama | Oren M Tepper | M. Silver | C. Kalka | Hong Ma | J. M. Isner | J. Isner | Marcy Silver
[1] E. Scott,et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion , 2002, Nature.
[2] Qi-Long Ying,et al. Changing potency by spontaneous fusion , 2002, Nature.
[3] S. Fichtlscherer,et al. Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.
[4] S. Homma,et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.
[5] T. Murohara,et al. Augmentation of Postnatal Neovascularization With Autologous Bone Marrow Transplantation , 2001, Circulation.
[6] J. Isner,et al. Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.
[7] E. Raines,et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. , 2000, Circulation research.
[8] B. Christy,et al. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. , 2000, The Journal of clinical investigation.
[9] S. Dirnhofer,et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells , 2000, The Lancet.
[10] J. Isner,et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Isner,et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.
[12] J. Isner,et al. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. , 1999, The Journal of clinical investigation.
[13] Haruchika Masuda,et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.
[14] J. Isner,et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. , 1998, Circulation research.
[15] S. Rafii,et al. Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.
[16] M. Kennedy,et al. A common precursor for hematopoietic and endothelial cells. , 1998, Development.
[17] Douglas Hanahan,et al. Signaling Vascular Morphogenesis and Maintenance , 1997, Science.
[18] J. Isner,et al. Histochemical staining following LacZ gene transfer underestimates transfection efficiency. , 1997, Human gene therapy.
[19] Thomas N. Sato,et al. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[20] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[21] J. Folkman,et al. A model of angiogenesis in the mouse cornea. , 1996, Investigative ophthalmology & visual science.
[22] Thomas N. Sato,et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.
[23] J. Gerdes,et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins , 1993, The Journal of cell biology.
[24] R. Hebbel,et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.
[25] A. Passaniti,et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.